Agios Pharma's total assets for Q3 2025 were $1.39B, a decrease of -5.81% from the previous quarter. AGIO total liabilities were $101.38M for the fiscal quarter, a -0.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.